February 8, 2024Open Access

Supplementary Figure 2 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

Los puntos clave no están disponibles para este artículo en este momento.

Tumor growth curves for tumors with varying MHC-I loss

Me gusta

Guardar

Ver artículo completo

Cite This Study

Taylor et al. (Thu,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar

Ver artículo completo